Outcome of Calcium Silicate Sealer-based Obturation in Root Canal Retreatment

Sponsor
Ministry of Health, Kuwait (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05714384
Collaborator
(none)
115
1
23.8
4.8

Study Details

Study Description

Brief Summary

This study will evaluate the outcome of calcium silicate sealer-based obturations in root canal retreatment.

Condition or Disease Intervention/Treatment Phase
  • Device: CeraSeal (Calcium Silicate-based Root Canal Sealer)

Detailed Description

There are a number of studies that have shown promising results with the use of calcium silicate sealer-based obturations in primary root canal treatments. However, to date, there is a lack of studies that evaluate the effectiveness of their use in secondary root canal treatments which are cases that typically present with more persistent infections. The aim of the proposed study is to assess the outcome of sealer-based obturations using a calcium silicate sealer in root canal retreatments and to identify potential predictor variables.

Questions:
  • What is the success rate of calcium silicate sealer-based obturations in root canal retreatment?

  • How does it compare to previous studies using conventional techniques?

  • What are the potential prognostic factors for success and failure?

This will be a prospective cohort study conducted at Jaber Al-Ahmed Specialty Dental Centre. Informed/written consent will be obtained from all patients. Root canal retreatments will be done by a specialist in endodontics using a calcium silicate-based sealer (CeraSeal, Meta Biomed) according to the best evidence-based standards. All of these treatments will be recorded into a database and be followed up by at least 12 months.

The clinical and radiographic records of each patient will be reviewed, and eligibility for the study was assessed based on inclusion and exclusion criteria. All data will be anonymized and extracted for analyses without a reference to participants.

The outcome at a specific time-point (12 months) will be a primary response variable of the analyses. Outcome will be the dependent variable in logistic regression models with different predictor variables: age, sex, tooth type, periapical status, preoperative pain, preoperative root filling quality, sinus tracts, presence of exudate during treatment, patency, apical size, sealer extrusion and weeks of medication. Separate simple logistic regressions will be performed for each predictor with the primary outcome. A sequential logistic regression model will then be used to assess outcome as a function of both independent measures. Two-way interactions between factors will also assessed.

Using the G-Power Version 3.1 program for conducting "Goodness of fit" chi-square test, it was determined for an estimated effect size of 0.30 and an alpha of 0.05, 88 teeth will be required to achieve a power of 80%. Adjusting for a dropout rate of 30%, the required sample size will be 115 teeth.

Study Design

Study Type:
Observational
Anticipated Enrollment :
115 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Outcome of Sealer-based Obturation Using a Calcium Silicate Sealer in Root Canal Retreatment: A CBCT-based Prospective Cohort Study
Anticipated Study Start Date :
Mar 5, 2023
Anticipated Primary Completion Date :
Feb 29, 2024
Anticipated Study Completion Date :
Feb 27, 2025

Outcome Measures

Primary Outcome Measures

  1. Assessment of radiographic healing with cone beam computed tomography (CBCT) scans using Estrela's PAI (periapical index) [Comparison of periapical lesion size at baseline and 12 months]

    Estrela's PAI based on CBCT will be used in logistic regression models with different predictor variables.

  2. Assessment of clinical outcome by assessing the resolution/persistence/development of clinical signs and symptoms [Comparison at baseline and 12 months]

    The examiner will label the teeth as having a normal clinical outcome (absence of pain, swelling and other symptoms, no sinus tract, no loss of function) or showing signs and symptoms clinical outcome (the tooth is associated with signs and/or symptoms of infection).

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participants must be 21-65 years of age at the time of recruitment

  • Participants must have a classification of I or II on the American Society of Anesthesiologists (ASA) physical status classification system

  • Participants must not have known allergies to any materials used in the study

  • Participants must agree to participate in the study by signing a consent form

  • All types of permanent teeth that require root canal retreatment are included (incisors, canines, premolars & molars)

  • The teeth must be restorable and have fully formed roots with no advanced periodontal disease

Exclusion Criteria:
  • ASA classification of III or more

  • Pregnant or breastfeeding women

  • Advanced periodontal disease or teeth with more than 5mm probing

  • Teeth with incomplete root formation

  • Teeth that have a poor restorative prognosis

  • Teeth presenting with signs of a vertical root fracture

  • Teeth with non-negotiable canals

  • Teeth with broken instruments

  • Teeth with perforations

  • Teeth requiring posts

  • Teeth with cracks

  • Teeth with internal or external root resorption

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jaber Al-Ahmed Dental Specialty Centre Janūb As Surrah Hawalli Governate Kuwait 00000

Sponsors and Collaborators

  • Ministry of Health, Kuwait

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ahmed Aldowaisan, Principal Investigator, Specialist in Endodontics, Ministry of Health, Kuwait
ClinicalTrials.gov Identifier:
NCT05714384
Other Study ID Numbers:
  • 2238
First Posted:
Feb 6, 2023
Last Update Posted:
Feb 10, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2023